Safety Data Sheet

SAFETY DATA SHEET

Date Accessed: 12/26/2024
Date Revised: 01/15/2022

SECTION 1. IDENTIFICATION

Product Name: Manganese Chloride Solution

Product Number: All applicable American Elements product codes, e.g. MN2-CL-02-SOL , MN2-CL-03-SOL , MN2-CL-04-SOL , MN2-CL-05-SOL

CAS #: 7773-01-5

Relevant identified uses of the substance: Scientific research and development

Supplier details:
American Elements
10884 Weyburn Ave.
Los Angeles, CA 90024
Tel: +1 310-208-0551
Fax: +1 310-208-0351

Emergency telephone number:
Domestic, North America: +1 800-424-9300
International: +1 703-527-3887


SECTION 2. HAZARDS IDENTIFICATION

2.1 Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
Serious eye damage (Category 1), H318
Specific target organ toxicity - repeated exposure, Inhalation (Category 2), Brain, H373
Acute aquatic toxicity (Category 3), H402
Chronic aquatic toxicity (Category 3), H412
2.2 GHS Label elements, including precautionary statements
Pictogram

Health Hazard - GHS08Corrosion - GHS05

Signal word Danger
Hazard statement(s)
H318 Causes serious eye damage.
H373 May cause damage to organs (Brain) through prolonged or repeated
exposure if inhaled.
H412 Harmful to aquatic life with long lasting effects.
Precautionary statement(s)
P260 Do not breathe dust/ fume/ gas/ mist/ vapors/ spray.
P273 Avoid release to the environment.
P280 Wear eye protection/ face protection.
P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing. Immediately
call a POISON CENTER or doctor/ physician.
P314 Get medical advice/ attention if you feel unwell.
P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Hazards not otherwise classified (HNOC) or not covered by GHS - none


SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

3.2 Mixtures
Hazardous components
Component Classification Concentration
Manganese dichloride
CAS-No.
EC-No.
7773-01-5
231-869-6
Acute Tox. 4; Eye Dam. 1;
STOT RE 2; Aquatic Acute 2;
Aquatic Chronic 2; H302,
H318, H373, H411
>= 10 - < 20 %
For the full text of the H-Statements mentioned in this Section, see Section 16.


SECTION 4. FIRST AID MEASURES

4.1 Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.Move out of dangerous area.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
4.2 Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11
4.3 Indication of any immediate medical attention and special treatment needed
No data available


SECTION 5. FIREFIGHTING MEASURES

5.1 Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
5.2 Special hazards arising from the substance or mixture
Hydrogen chloride gas, Manganese/manganese oxides
5.3 Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
5.4 Further information
No data available


SECTION 6. ACCIDENTAL RELEASE MEASURES

6.1 Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Evacuate
personnel to safe areas.
For personal protection see section 8.
6.2 Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment
must be avoided.
6.3 Methods and materials for containment and cleaning up
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed containers for
disposal.
6.4 Reference to other sections
For disposal see section 13.


SECTION 7. HANDLING AND STORAGE

7.1 Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapor or mist.
For precautions see section 2.2.
7.2 Conditions for safe storage, including any incompatibilities
Keep container tightly closed in a dry and well-ventilated place. Containers which are opened must be carefully
resealed and kept upright to prevent leakage.
Storage class (TRGS 510): Non Combustible Liquids
7.3 Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated


SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

8.1 Control parameters
Components with workplace control parameters
Component CAS-No. Value Control
parameters
Basis
Manganese dichloride
7773-01-5 C 5.000000 mg/m3
USA. Occupational Exposure Limits
(OSHA) - Table Z-1 Limits for Air
Contaminants
Remarks Ceiling limit is to be determined from breathing-zone air samples.
TWA 0.200000
mg/m3
USA. ACGIH Threshold Limit Values
(TLV)
Central Nervous System impairment
Adopted values or notations enclosed are those for which changes
are proposed in the NIC
See Notice of Intended Changes (NIC)
varies
TWA 1.000000
mg/m3
USA. NIOSH Recommended
Exposure Limits
ST 3.000000
mg/m3
USA. NIOSH Recommended
Exposure Limits
TWA 0.100000
mg/m3
USA. ACGIH Threshold Limit Values
(TLV)
Central Nervous System impairment
2015 Adoption
varies
TWA 0.020000
mg/m3
USA. ACGIH Threshold Limit Values
(TLV)
Central Nervous System impairment
2015 Adoption
varies
C 5 mg/m3 USA. Occupational Exposure Limits
(OSHA) - Table Z-1 Limits for Air
Contaminants
Ceiling limit is to be determined from breathing-zone air samples.
TWA 0.1 mg/m3 USA. ACGIH Threshold Limit Values
(TLV)
Central Nervous System impairment
Not classifiable as a human carcinogen
varies
TWA 0.02 mg/m3 USA. ACGIH Threshold Limit Values
(TLV)
Central Nervous System impairment
Not classifiable as a human carcinogen
varies
TWA 1 mg/m3 USA. NIOSH Recommended
Exposure Limits
ST 3 mg/m3 USA. NIOSH Recommended
Exposure Limits
8.2 Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of
workday.
Personal protective equipment
Eye/face protection
Tightly fitting safety goggles. Faceshield (8-inch minimum). Use equipment for eye protection tested and
approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without
touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after
use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected according to
the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator with multipurpose
combination (US) or type ABEK (EN 14387) respirator cartridges as a backup to engineering controls.
If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and
components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
environment must be avoided.


SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties
a) Appearance Form: liquid
b) Odor No data available
c) Odor Threshold No data available
d) pH No data available
e) Melting point/freezing
point
No data available
f) Initial boiling point and
boiling range
No data available
g) Flash point No data available
h) Evaporation rate No data available
i) Flammability (solid, gas) No data available
j) Upper/lower
flammability or
explosive limits
No data available
k) Vapor pressure No data available
l) Vapor density No data available
m) Relative density No data available
n) Water solubility No data available
o) Partition coefficient: noctanol/
water
No data available
p) Auto-ignition
temperature
No data available
q) Decomposition
temperature
No data available
r) Viscosity No data available
s) Explosive properties No data available
t) Oxidizing properties No data available
9.2 Other safety information
No data available


SECTION 10. STABILITY AND REACTIVITY

10.1 Reactivity
No data available
10.2 Chemical stability
Stable under recommended storage conditions.
10.3 Possibility of hazardous reactions
No data available
10.4 Conditions to avoid
No data available
10.5 Incompatible materials
Zinc, Potassium, Strong acids, Sodium/sodium oxides, Hydrogen peroxide
10.6 Hazardous decomposition products
Other decomposition products - No data available
In the event of fire: see section 5


SECTION 11. TOXICOLOGICAL INFORMATION

11.1 Information on toxicological effects
Acute toxicity
No data available
Inhalation: No data available
Dermal: No data available
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
NTP: No component of this product present at levels greater than or equal to 0.1% is identified as a
known or anticipated carcinogen by NTP.
OSHA: No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by OSHA.
Reproductive toxicity
No data available
No data available
Specific target organ toxicity - single exposure
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available
Men exposed to manganese dusts showed a decrease in fertility. Chronic manganese poisoning primarily involves the
central nervous system. Early symptoms include languor, sleepiness and weakness in the legs. A stolid mask-like
appearance of the face, emotional disturbances such as uncontrollable laughter and a spastic gait with tendency to fall
in walking are findings in more advanced cases. High incidence of pneumonia has been found in workers exposed to
the dust or fume of some manganese compounds., To the best of our knowledge, the chemical, physical, and
toxicological properties have not been thoroughly investigated.
Stomach - Irregularities - Based on Human Evidence
Stomach - Irregularities - Based on Human Evidence (Manganese dichloride)


SECTION 12. ECOLOGICAL INFORMATION

12.1 Toxicity
No data available
12.2 Persistence and degradability:
No data available
12.3 Bioaccumulative potential:
No data available
12.4 Mobility in soil:
No data available
12.5 Results of PBT and vPvB assessment:
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
12.6 Other adverse effects
An environmental hazard cannot be excluded in the event of unprofessional handling or disposal.
Harmful to aquatic life with long lasting effects.


SECTION 13. DISPOSAL CONSIDERATIONS

13.1 Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional waste
disposal service to dispose of this material.
Contaminated packaging
Dispose of as unused product.


SECTION 14. TRANSPORT INFORMATION

DOT (US)
Not dangerous goods
IMDG
Not dangerous goods
IATA
Not dangerous goods


SECTION 15. REGULATORY INFORMATION

SARA 302 Components
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components
The following components are subject to reporting levels established by SARA Title III, Section 313:
Manganese dichloride
CAS-No.
7773-01-5
Revision Date
2007-07-01
SARA 311/312 Hazards
Acute Health Hazard, Chronic Health Hazard
Massachusetts Right To Know Components
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components
Water
CAS-No.
7732-18-5
Revision Date
Manganese dichloride 7773-01-5 2007-07-01
New Jersey Right To Know Components
Water
CAS-No.
7732-18-5
Revision Date
Manganese dichloride 7773-01-5 2007-07-01
California Prop. 65 Components
This product does not contain any chemicals known to State of California to cause cancer, birth defects, or any other
reproductive harm.